Search research articles
Contact Us
Filters
Showing results (71-80 of 78) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 78 results.
Disease Markers
|
September 1, 1993
Glutathione transferase GST pi in breast tumors evaluated by three techniques
R Molina, S Oesterreich, J L Zhou, et al.
Breast Cancer Research and Treatment
|
May 1, 1997
Cytological evaluation of biological prognostic markers from primary breast carcinomas
A Makris, D C Allred, T J Powles, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1997
bcl-2, p53, and response to tamoxifen in estrogen receptor-positive metastatic breast cancer: a Southwest Oncology Group study
R M Elledge, S Green, L Howes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 1, 1997
Prediction of response to neoadjuvant chemoendocrine therapy in primary breast carcinomas
A Makris, T J Powles, M Dowsett, et al.
Endocrine-Related Cancer
|
August 23, 2005
Growth factor signalling and response to endocrine therapy: the Royal Marsden Experience
M Dowsett, S Johnston, L-A Martin, et al.
Endocrinology
|
May 15, 2003
Developmental and hormonal signals dramatically alter the localization and abundance of insulin receptor substrate proteins in the mammary gland
A V Lee, P Zhang, M Ivanova, et al.
Cell Death and Differentiation
|
September 17, 2013
Dysregulated STAT1-SOCS1 control of JAK2 promotes mammary luminal progenitor cell survival and drives ERα(+) tumorigenesis
S R Chan, C G Rickert, W Vermi, et al.
Archives of Pathology & Laboratory Medicine
|
July 11, 2000
Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999
P L Fitzgibbons, D L Page, D Weaver, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 78) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 78 results.
Disease Markers
|
September 1, 1993
Glutathione transferase GST pi in breast tumors evaluated by three techniques
R Molina, S Oesterreich, J L Zhou, et al.
Breast Cancer Research and Treatment
|
May 1, 1997
Cytological evaluation of biological prognostic markers from primary breast carcinomas
A Makris, D C Allred, T J Powles, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1997
bcl-2, p53, and response to tamoxifen in estrogen receptor-positive metastatic breast cancer: a Southwest Oncology Group study
R M Elledge, S Green, L Howes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 1, 1997
Prediction of response to neoadjuvant chemoendocrine therapy in primary breast carcinomas
A Makris, T J Powles, M Dowsett, et al.
Endocrine-Related Cancer
|
August 23, 2005
Growth factor signalling and response to endocrine therapy: the Royal Marsden Experience
M Dowsett, S Johnston, L-A Martin, et al.
Endocrinology
|
May 15, 2003
Developmental and hormonal signals dramatically alter the localization and abundance of insulin receptor substrate proteins in the mammary gland
A V Lee, P Zhang, M Ivanova, et al.
Cell Death and Differentiation
|
September 17, 2013
Dysregulated STAT1-SOCS1 control of JAK2 promotes mammary luminal progenitor cell survival and drives ERα(+) tumorigenesis
S R Chan, C G Rickert, W Vermi, et al.
Archives of Pathology & Laboratory Medicine
|
July 11, 2000
Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999
P L Fitzgibbons, D L Page, D Weaver, et al.
Page
of 8